Novo Nordisk launches $9B bid to acquire Metsera, outpacing Pfizer's earlier offer, in a fierce competition to dominate the lucrative obesity drug market.
Trump and Xi agree to de-escalate trade tensions, extend truce and cut tariffs, with further negotiations on remaining disputes.
Novo Nordisk launches $9B bid to acquire Metsera, outpacing Pfizer's earlier offer, in a fierce competition to dominate the lucrative obesity drug market.
Trump and Xi agree to de-escalate trade tensions, extend truce and cut tariffs, with further negotiations on remaining disputes.